High c-myb expression has been associated with oncogenic activity and poor prognosis in several human cancers, including T-cell leukemia, acute myelogenous leukemia, colorectal tumors, breast cancer, and most recently, adenoid cystic carcinomas [35], [44], [45]. Here, MYB is linked to breast cancer.